Clinical trial
The Safety and Efficacy of MULTIHANCE at the Dose of 0.10 mmol/kg in Magnetic Resonance Imaging of the Central Nervous System in Pediatric Patients Who Are Less Than 2 Years of Age
NCT02291822 is registered in ClinicalTrials.gov with Bracco Diagnostics, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Safety and Efficacy of MULTIHANCE at the Dose of 0.10 mmol/kg in Magnetic Resonance Imaging of the Central Nervous System in Pediatric Patients Who Are Less Than 2 Years of Age
- Lead sponsor
- Bracco Diagnostics, Inc
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2014
- Completion date
- December 31, 2015
- Enrollment
- 90 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
central nervous system disease, central nervous system neoplasms